Word

60 SECOND

Status

Dead

Status Code

602

Status Date

Tuesday, June 2, 2020

Serial Number

88263443

Mark Type

4000

Filing Date

Wednesday, January 16, 2019

Abandoned Date

Tuesday, April 21, 2020

Trademark Owner History

Essenlix Corporation

Classifications

1 Assays for research purposes; Biological and chemical reagents used for non-medical purposes, in vitro and in vivo scientific use, the testing of bodily fluids, and the detecting and analyzing of cells, proteins, small molecules, and nucleotides; Biological and chemical test kits for laboratory or research use in the field of personal wellness; Biological and chemical test kits for laboratory or research use for the detection and identification of nucleic acids, namely, DNA and RNA in a sample

5 Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents and assays for testing cells, proteins, small molecules, nucleotides, and nucleic acids; Medical diagnostic reagents; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic biomarker reagents for medical purposes

10 Medical diagnostic apparatus for testing cells, tissue, biomolecules, proteins, small molecules, and nucleotides; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic use, namely, medical apparatus for diagnostic testing of health conditions, diseases, or abnormalities in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and endocrine diseases, and other tissue-based diagnostic testing, cytology, and cell based testing; Medical apparatus, devices, and instruments for wellness testing, health condition testing, and healthcare testing, namely, point-of-care diagnostic devices, at-home diagnostic devices, and portable health monitoring devices that detect health conditions and diseases in the nature of cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical apparatus, devices, and instruments for the detection and identification of nucleic acids, namely, DNA and RNA in a sample

44 Medical services; Medical assistance; Medical consultations; Medical counseling; Medical information; Healthcare services in the field of digital healthcare services; Diagnostic services, namely, medical testing for diagnostic purposes; Wellness services, namely, providing wellness information; Medical services, medical assistance, medical consultations, medical counseling, medical information, healthcare testing, diagnostic testing, and wellness services, all in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing; Medical testing services for the detection and identification of cells, proteins, small molecules, and nucleic acids in a sample

SIXTY SECOND

Trademark Events

Jun 2, 2020

Abandonment Notice E-Mailed - Failure To Respond

Jun 2, 2020

Abandonment - Failure To Respond Or Late Response

Oct 18, 2019

Notification Of Final Refusal Emailed

Oct 18, 2019

Final Refusal E-Mailed

Oct 18, 2019

Final Refusal Written

Oct 1, 2019

Teas/Email Correspondence Entered

Oct 1, 2019

Correspondence Received In Law Office

Sep 30, 2019

Assigned To Lie

Sep 23, 2019

Teas Response To Office Action Received

Mar 23, 2019

Notification Of Non-Final Action E-Mailed

Mar 23, 2019

Non-Final Action E-Mailed

Mar 23, 2019

Non-Final Action Written

Mar 22, 2019

Assigned To Examiner

Feb 7, 2019

New Application Office Supplied Data Entered In Tram

Jan 19, 2019

New Application Entered In Tram